Nuvig Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Nuvig Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia (NCT07095127) | Nuvig Therapeutics, Inc. | 2025-09-30 |
| Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP (NCT07027111) | Nuvig Therapeutics, Inc. | 2025-04-25 |
Track Nuvig Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.